MDVZX
Price
$9.26
Change
+$0.02 (+0.22%)
Updated
Nov 8 closing price
VIVAX
Price
$69.72
Change
+$0.39 (+0.56%)
Updated
Nov 8 closing price
Ad is loading...

MDVZX vs VIVAX

Header iconMDVZX vs VIVAX Comparison
Open Charts MDVZX vs VIVAXBanner chart's image
Manning & Napier Disciplined Value Z
Price$9.26
Change+$0.02 (+0.22%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$69.72
Change+$0.39 (+0.56%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MDVZX vs VIVAX Comparison Chart
Loading...
VS
MDVZX vs. VIVAX commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDVZX is a StrongBuy and VIVAX is a Buy.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. MDVZX (197M). MDVZX pays higher dividends than VIVAX: MDVZX (2.92) vs VIVAX (2.25). MDVZX was incepted earlier than VIVAX: MDVZX (6 years) vs VIVAX (32 years). MDVZX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than MDVZX: VIVAX (3000) vs MDVZX (1000000). VIVAX annual gain was more profitable for investors over the last year : 31.29 vs. MDVZX (24.55). VIVAX return over 5 years is better than : 53.45 vs. MDVZX (25.02).
MDVZXVIVAXMDVZX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years32 years-
Gain YTD17.13419.62887%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets197M184B0%
Annual Yield % from dividends2.922.25130%
Returns for 1 year24.5531.2978%
Returns for 3 years1.5123.376%
Returns for 5 years25.0253.4547%
Returns for 10 yearsN/A114.70-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INAB0.340.01
+3.93%
IN8bio
SMID37.361.11
+3.06%
Smith-Midland Corp
ARES170.382.11
+1.25%
Ares Management Corp
AVNT51.560.11
+0.21%
Avient Corp
LAB2.15-0.03
-1.38%
Standard BioTools